Bridgeway Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Sell
225,105
-39,956
-15% -$4.61M 0.54% 18
2025
Q4
$27.9M Sell
265,061
-43,895
-14% -$4.12M 0.58% 14
2025
Q3
$25.9M Buy
308,956
+16,772
+6% +$1.38M 0.55% 13
2025
Q2
$23.1M Buy
292,184
+45,671
+19% +$3.63M 0.55% 16
2025
Q1
$22.1M Buy
246,513
+31,401
+15% +$2.93M 0.56% 16
2024
Q4
$21.4M Buy
215,112
+29,549
+16% +$3.05M 0.48% 24
2024
Q3
$21.1M Buy
185,563
+24,611
+15% +$2.92M 0.46% 27
2024
Q2
$19.9M Buy
160,952
+13,021
+9% +$1.68M 0.47% 23
2024
Q1
$19.5M Sell
147,931
-5,062
-3% -$624K 0.4% 30
2023
Q4
$16.7M Buy
152,993
+34,562
+29% +$3.59M 0.36% 43
2023
Q3
$12.2M Buy
118,431
+8,610
+8% +$928K 0.3% 66
2023
Q2
$12.7M Buy
109,821
+81,786
+292% +$9.29M 0.3% 52
2023
Q1
$2.98M Sell
28,035
-1,750
-6% -$189K 0.08% 410
2022
Q4
$3.3M Sell
29,785
-28,600
-49% -$2.92M 0.09% 388
2022
Q3
$5.03M Sell
58,385
-30,700
-34% -$2.74M 0.13% 258
2022
Q2
$8.12M Sell
89,085
-34,500
-28% -$3.06M 0.19% 175
2022
Q1
$10.1M Sell
123,585
-10,850
-8% -$855K 0.2% 161
2021
Q4
$10.3M Sell
134,435
-205,400
-60% -$16.4M 0.19% 155
2021
Q3
$25.5M Sell
339,835
-38,500
-10% -$2.93M 0.49% 17
2021
Q2
$29.4M Sell
378,335
-17,531
-4% -$1.3M 0.53% 17
2021
Q1
$29.1M Buy
395,866
+35,213
+10% +$2.6M 0.54% 16
2020
Q4
$28.1M Sell
360,653
-23,266
-6% -$1.78M 0.6% 15
2020
Q3
$30.4M Buy
383,919
+230,665
+151% +$18.1M 0.7% 10
2020
Q2
$11.3M Buy
153,254
+7,021
+5% +$529K 0.23% 112
2020
Q1
$10.7M Sell
146,233
-816,392
-85% -$64.2M 0.25% 104
2019
Q4
$83.5M Sell
962,625
-256,340
-21% -$21.1M 1.12% 5
2019
Q3
$97.9M Sell
1,218,965
-42,759
-3% -$3.43M 1.35% 2
2019
Q2
$101M Sell
1,261,724
-9,903
-0.8% -$758K 1.29% 3
2019
Q1
$101M Buy
1,271,627
+46,321
+4% +$3.46M 1.26% 5
2018
Q4
$89.3M Buy
1,225,306
+954,361
+352% +$67.4M 1.19% 6
2018
Q3
$18.3M Buy
270,945
+24,314
+10% +$1.55M 0.18% 113
2018
Q2
$14.3M Sell
246,631
-13,876
-5% -$783K 0.15% 125
2018
Q1
$13.5M Sell
260,507
-5,240
-2% -$283K 0.15% 134
2017
Q4
$14.3M Buy
265,747
+33,924
+15% +$1.88M 0.15% 126
2017
Q3
$14.2M Buy
231,823
+12,650
+6% +$767K 0.16% 123
2017
Q2
$13.4M Sell
219,173
-12,157
-5% -$740K 0.16% 128
2017
Q1
$14M Sell
231,330
-32,310
-12% -$1.96M 0.17% 126
2016
Q4
$14.8M Buy
263,640
+24,135
+10% +$1.41M 0.19% 130
2016
Q3
$14.3M Sell
239,505
-37,518
-14% -$2.19M 0.21% 118
2016
Q2
$15.2M Sell
277,023
-75,267
-21% -$4.01M 0.24% 124
2016
Q1
$17.8M Buy
352,290
+11,150
+3% +$546K 0.3% 111
2015
Q4
$17.2M Sell
341,140
-5,879
-2% -$296K 0.32% 102
2015
Q3
$16.4M Buy
347,019
+16,485
+5% +$876K 0.34% 97
2015
Q2
$18M Sell
330,534
-31,450
-9% -$1.76M 0.35% 84
2015
Q1
$19.9M Sell
361,984
-111,235
-24% -$6.3M 0.41% 54
2014
Q4
$25.6M Buy
473,219
+31,146
+7% +$1.74M 0.58% 21
2014
Q3
$25M Buy
442,073
+5,764
+1% +$324K 0.63% 17
2014
Q2
$24.1M Sell
436,309
-11,863
-3% -$647K 0.63% 17
2014
Q1
$24.3M Buy
448,172
+70,268
+19% +$3.64M 0.69% 9
2013
Q4
$18M Sell
377,904
-2,420
-0.6% -$111K 0.55% 33
2013
Q3
$17.3M Buy
380,324
+9,694
+3% +$443K 0.59% 33
2013
Q2
$16.4M Buy
+370,630
New +$16.6M 0.66% 33

Other funds holding MRK

Bridgeway Capital Management's MRK Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Merck (MRK) stake by 15% in Q1 2026, selling an estimated $4.61M and leaving 225,105 shares worth $27.1M. The position accounts for 0.54% of the portfolio, ranked #18.

Bridgeway Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q2 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bridgeway Capital Management held 225,105 shares of Merck worth $27.1M as of Q1 2026.
  • Bridgeway Capital Management sold 39,956 Merck shares in Q1 2026, an estimated $4.61M.
  • Merck made up 0.54% of Bridgeway Capital Management's portfolio in Q1 2026, its #18 holding.
  • Bridgeway Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bridgeway Capital Management's Merck position peaked at $101M in Q2 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.